comparemela.com

Latest Breaking News On - Cenova capital - Page 2 : comparemela.com

Biotech startup Eluminex bags $40m Series B funding led by Cenova Capital

The round also saw participation from 3E Bioventures Capital, and Oriza Holdings.

Eluminex biosciencesOriza holdingsGuangzhou yuexiu industrial investment fund managementCenova capitalBioventures capitalLilly asia venturesHillhouse capitalHemay pharmaceuticalPulnovo medical

Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology

/PRNewswire/ Eluminex Biosciences (Suzhou) Limited (Eluminex) officially announced today the closing of a Series B financing of over $40 million (USD)..

United statesSouth san franciscoJinzhong zhangEluminex biosciences suzhouEluminex biosciences suzhou limitedOriza holdingsGuangzhou yuexiu industrial investment fund managementEluminex biosciencesCenova capitalBioventures capitalSuzhou industrial parkLilly asia venturesHillhouse capital

Pulnovo Medical Inhales Tens of Millions Dollars Funding to Accelerate Global Growth

/PRNewswire/ Pulnovo Medical Limited, a globally recognized OTM (From Operating Table to Market) innovative platform, today announced the successful close.

Cynthia chenChina national medical products administrationOrbimed healthcare fund managementPrnewswire pulnovo medicalMedical limitedFrom operating tableYuanbio venture capitalCenova capitalLilly asia venturesGaorong capitalHuihe capitalPulmonary artery denervationGlobal trialNational medical products administrationChief strategy officerPulnovo medical

Pulnovo Medical Raises Tens of Millions Dollars Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Orbimed healthcare fund managementNational medical products administrationPulnovo medicalFrom operating tableYuanbio venture capitalCenova capitalLilly asia venturesGaorong capitalHuihe capitalPulmonary artery denervationGlobal trial

Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform

/PRNewswire/ Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new.

United statesHong kongYu zengDaniel tangMinchuan wangWensheng weiChangzu caiH healthH health investmentTherorna incWei labSherpa healthcare partnersHealth investmentQuan capitalCenova capitalProfessor wensheng wei

vimarsana © 2020. All Rights Reserved.